CORT Q3 2020 Earnings — Corcept Therapeutics Incorporated Revenue & Financial Results | Market Cap Arena

CORTCorcept Therapeutics Incorporated

$4B

Q3 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$86M+5.9% YoY

Gross Profit

$85M98.6% margin

Operating Income

$25M28.6% margin

Net Income

$22M25.1% margin

EPS (Diluted)

$0.17

QoQ Revenue Growth

-2.5%

Cash Flow

Operating Cash Flow

$30M

Free Cash Flow

$30M

Stock-Based Comp.

$9M

Balance Sheet

Total Assets

$534M

Total Liabilities

$44M

Stockholders' Equity

$490M

Cash & Equivalents

$31M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$86M	$82M	+5.9%
Gross Profit	$85M	$80M	+6.3%
Operating Income	$25M	$33M	-25.1%
Net Income	$22M	$26M	-17.9%